News
-
-
PRESS RELEASE
EQS-Adhoc: Entering into agreements for the acquisition of a majority stake in OTRS AG by Optimus BidCo AG, an acquisition company of Easyvista SAS, for a purchase price of EUR 17 per share
OTRS AG to be acquired by Optimus BidCo AG for EUR 17 per share, forming a strategic partnership with Easyvista SAS in the IT Service Management market -
-
-
-
PRESS RELEASE
The Komax Group is making good progress in the implementation of its strategy
Komax Group progresses in strategy implementation, adjusts mid-term targets due to challenging market environment. Strengthened position in China, optimized distribution network, reduced costs. Change in forecast and Executive Committee -
-
PRESS RELEASE
Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Protagonist Therapeutics announces selection of PN-881, an oral peptide interleukin-17 antagonist, as a development candidate for immune-mediated skin diseases. IND enabling studies ongoing with Phase I expected in Q425 -
-
PRESS RELEASE
Inventiva publie ses informations financières du 3ème trimestre 2024¹
Inventiva publie ses informations financi\u00e8res du 3\u00e8me trimestre 2024 avec tr\u00e9sorerie de 13,9 millions d'euros, chiffre d'affaires de 1,3 million sur neuf mois, \u00e9mission de certificats de redevance, pr\u00e9visions de financement jusqu'en 2025
